Valley National Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-25
| Closed | -$6K | – | 753 |
|
|
2024
Q2 | $6K | Buy |
25
+10
| +67% | +$2.4K | ﹤0.01% | 708 |
|
|
2024
Q1 | $2K | Sell |
15
-71
| -83% | -$9.47K | ﹤0.01% | 922 |
|
|
2023
Q4 | $16K | Buy |
86
+10
| +13% | +$1.86K | ﹤0.01% | 569 |
|
|
2023
Q3 | $13K | Buy |
76
+1
| +1% | +$171 | ﹤0.01% | 556 |
|
|
2023
Q2 | $15K | Buy |
75
+4
| +6% | +$800 | ﹤0.01% | 542 |
|
|
2023
Q1 | $15K | Sell |
71
-12
| -14% | -$2.54K | ﹤0.01% | 535 |
|
|
2022
Q4 | $18K | Buy |
83
+3
| +4% | +$651 | ﹤0.01% | 502 |
|
|
2022
Q3 | $16K | Buy |
+80
| New | +$16K | ﹤0.01% | 524 |
|
|
2020
Q2 | – | Sell |
-6
| Closed | -$1K | – | 770 |
|
|
2020
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 667 |
|
|
2019
Q4 | $1K | Sell |
6
-6
| -50% | -$1K | ﹤0.01% | 699 |
|
|
2019
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 701 |
|
|
2019
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 670 |
|
|
2019
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 670 |
|
|
2018
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 689 |
|
|
2018
Q3 | $1K | Sell |
12
-11
| -48% | -$917 | ﹤0.01% | 617 |
|
|
2018
Q2 | $2K | Buy |
+23
| New | +$2K | ﹤0.01% | 547 |
|